Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy

Saved in:
Bibliographic Details
Main Authors: Luciano J. Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai R. Dholaria, Kelly N. Godby, Susan Bal, Gayathri Ravi, Smith Giri, Saurabh Chhabra, Rebecca Silbermann, Natalie S. Callander
Format: Article
Language:English
Published: Nature Publishing Group 2025-02-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01219-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863261831888896
author Luciano J. Costa
Eva Medvedova
Binod Dhakal
Bhagirathbhai R. Dholaria
Kelly N. Godby
Susan Bal
Gayathri Ravi
Smith Giri
Saurabh Chhabra
Rebecca Silbermann
Natalie S. Callander
author_facet Luciano J. Costa
Eva Medvedova
Binod Dhakal
Bhagirathbhai R. Dholaria
Kelly N. Godby
Susan Bal
Gayathri Ravi
Smith Giri
Saurabh Chhabra
Rebecca Silbermann
Natalie S. Callander
author_sort Luciano J. Costa
collection DOAJ
format Article
id doaj-art-3fa811b5bad9466381a1396dd68dcc3b
institution Kabale University
issn 2044-5385
language English
publishDate 2025-02-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj-art-3fa811b5bad9466381a1396dd68dcc3b2025-02-09T12:13:07ZengNature Publishing GroupBlood Cancer Journal2044-53852025-02-011511410.1038/s41408-025-01219-7Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapyLuciano J. Costa0Eva Medvedova1Binod Dhakal2Bhagirathbhai R. Dholaria3Kelly N. Godby4Susan Bal5Gayathri Ravi6Smith Giri7Saurabh Chhabra8Rebecca Silbermann9Natalie S. Callander10Division of Hematology/Oncology, University of Alabama at BirminghamDivision of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science UniversityDivision of Hematology/Oncology, Department of Medicine, Medical College of WisconsinDepartment of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical CenterDivision of Hematology/Oncology, University of Alabama at BirminghamDivision of Hematology/Oncology, University of Alabama at BirminghamDivision of Hematology/Oncology, University of Alabama at BirminghamDivision of Hematology/Oncology, University of Alabama at BirminghamDivision of Hematology/Oncology, Department of Medicine, Medical College of WisconsinDivision of Hematology/Oncology, Knight Cancer Institute, Oregon Health & Science UniversityUniversity of Wisconsinhttps://doi.org/10.1038/s41408-025-01219-7
spellingShingle Luciano J. Costa
Eva Medvedova
Binod Dhakal
Bhagirathbhai R. Dholaria
Kelly N. Godby
Susan Bal
Gayathri Ravi
Smith Giri
Saurabh Chhabra
Rebecca Silbermann
Natalie S. Callander
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Blood Cancer Journal
title Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
title_full Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
title_fullStr Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
title_full_unstemmed Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
title_short Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
title_sort implications of isolated mrd progression in newly diagnosed multiple myeloma treated with quadruplet therapy
url https://doi.org/10.1038/s41408-025-01219-7
work_keys_str_mv AT lucianojcosta implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT evamedvedova implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT binoddhakal implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT bhagirathbhairdholaria implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT kellyngodby implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT susanbal implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT gayathriravi implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT smithgiri implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT saurabhchhabra implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT rebeccasilbermann implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy
AT nataliescallander implicationsofisolatedmrdprogressioninnewlydiagnosedmultiplemyelomatreatedwithquadruplettherapy